FDA Authorizes Updated Covid-19 Vaccines By Moderna, Pfizer
Portfolio Pulse from Benzinga Newsdesk
The FDA has authorized updated Covid-19 vaccines developed by Moderna and Pfizer. This decision is expected to impact the stock prices of both companies as they prepare to distribute the new vaccines.
August 22, 2024 | 5:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The FDA's authorization of Moderna's updated Covid-19 vaccine is likely to positively impact the company's stock as it prepares for distribution.
The FDA's authorization is a significant regulatory milestone for Moderna, likely boosting investor confidence and stock price as the company moves towards distributing the updated vaccine.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Pfizer's stock is expected to see a positive impact following the FDA's authorization of its updated Covid-19 vaccine, as the company prepares for distribution.
The FDA's authorization is a crucial step for Pfizer, likely enhancing investor sentiment and stock performance as the company gears up for vaccine distribution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90